发明名称 HETEROCYCLIC COMPOUND HAVING ANGIOTENSIN II ANTAGONISTIC ACTION
摘要 <p>PROBLEM TO BE SOLVED: To provide a new compound having strong angiotensin II antagonistic action, hypotensive action and central nervous action and useful for the treatment of circulatory diseases such as hypertension, cardiac diseases, cerebral apoplexy, nephritis and arteriosclerosis, Alzheimers disease, senile dementia, etc. SOLUTION: This compound is expressed by the formula I [R<1> is a (substituted)hydrocarbon group which may be bonded through hetero-atom; R<2> is a (substituted)heterocyclic residue having a ring-constituting group; X is bonded to rings Y and W; W and Y are each a (substituted)aromatic hydrocarbon residue which may contain hetero-atom or a heterocyclic residue; (n) is 1 or 2; (a) and (b) are each a (substituted)C or a hetero-atom; (c) is a (substituted)C, a hetero-atom, etc.], e.g. 2-ethoxy-1-[[2'-(2,5-dihydro-5-oxo-1,2,4- thiadiazol-3-yl)biphenyl-4-yl]methy]benzimidazole-7-carboxylic acid. The compound of the formula I can be produced by reacting a compound of the formula II with a compound of the formula III (L is a halogen) and, as necessary, properly subjecting the reaction product to hydrolysis, reduction, halogenation, O-, N- or S-alkylation, nucleophilic reaction, cyclization, acylation, etc.</p>
申请公布号 JPH09183778(A) 申请公布日期 1997.07.15
申请号 JP19960320175 申请日期 1996.11.29
申请人 TAKEDA CHEM IND LTD 发明人 NAKA TATSUHIKO;INADA YOSHIYUKI
分类号 A61K31/415;A61K31/41;A61K31/42;A61K31/4245;A61K31/433;A61K31/435;A61K31/4365;A61K31/495;A61K31/505;A61K31/513;A61K31/517;A61K31/535;A61P9/00;A61P9/10;A61P9/12;A61P25/28;A61P43/00;B29D22/00;B32B27/42;C07D285/08;C07D403/10;C07D413/10;C07D417/10;C07D419/10;C07D471/04;C07D487/04;C07D495/04;C07D519/00;(IPC1-7):C07D413/10 主分类号 A61K31/415
代理机构 代理人
主权项
地址